The Patent Finder

NRL Pharma, Inc.

Also on record
Records under this name other than patents NRL Pharma, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 8 of 8 · Back to NRL Pharma, Inc.

PatentTitleStatus Expires Confidence
US 10,562,959Lactoferrin fusion protein and method for preparation thereof
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,809,641Lactoferrin fusion protein and method for preparation thereof
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,041,014Lactoferrin/albumin fusion protein and production method therefor
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,968,186Ascochlorin derivative and use thereof as AMPK activator
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,399,414Analgesics
Term ended
Term ended Jan 17, 2023 · From the USPTO record
Term endedTerm ended Jan 17, 2023From the USPTO record
US 8,673,839Lactoferrin complex and method of producing the same
Lapsed on the fee record
Ended Mar 18, 2022 · From the USPTO record
Lapsed on the fee recordEnded Mar 18, 2022From the USPTO record
US 7,629,471Transcriptional factor, process for producing the same and use thereof
Lapsed on the fee record
Ended Dec 8, 2021 · From the USPTO record
Lapsed on the fee recordEnded Dec 8, 2021From the USPTO record
US 7,432,306Method for preparing novel transcription factors and use
Lapsed on the fee record
Ended Oct 7, 2020 · From the USPTO record
Lapsed on the fee recordEnded Oct 7, 2020From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited